InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ZEVRA THERAPEUTICS, INC.

ZVRA Clue Score60
United States Fiscal year ends December CIK 0001434647 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Neil F. McFarlane
12 Oct 2026
President and CEO
Sold on a plan
20,000
$11.25
$224.95K
Rahsaan Thompson
14 Aug 2026
Chief Legal & Compliance
Sold on a plan
42,666
$11.13
$474.77K
Corey Michael Watton
10 Aug 2026
Director
Sold after exercise
12,300
$11.25
$138.38K
Rahsaan Thompson
22 Jun 2026
Chief Legal & Compliance
Sold on a plan
34,557
$12.68
$438.30K
Rahsaan Thompson
11 May 2026
Chief Legal & Compliance
Sold on a plan
1,794
$11.30
$20.27K
John B Bode
24 Mar 2026
Director
Exercised, kept
39,200
$4.89
$191.69K
John B Bode
24 Mar 2026
Director
Exercised, kept
39,200
$4.97
$194.82K
Neil F. McFarlane
9 Feb 2026
President and CEO
Sold on a plan
14,625
$8.56
$125.19K
Joshua Schafer
3 Feb 2026
CCO
Sold on a plan
10,500
$9.19
$96.50K
Timothy J. Sangiovanni
3 Feb 2026
SVP, Finance & Corp Controller
Sold on a plan
3,000
$9.18
$27.55K
Neil F. McFarlane
2 Feb 2026
President and CEO
Sold on a plan
91,000
$9.38
$853.43K
Joshua Schafer
30 Jan 2026
CCO
Sold after exercise
3,375
$8.83
$29.80K
Adrian W Quartel
30 Jan 2026
Chief Medical Officer
Sold after exercise
4,533
$8.83
$40.04K
Rahsaan Thompson
30 Jan 2026
Chief Legal & Compliance
Sold after exercise
4,080
$8.83
$36.01K
Timothy J. Sangiovanni
30 Jan 2026
SVP, Finance & Corp Controller
Sold after exercise
1,750
$8.82
$15.44K

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 5
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 754,713
History held since 17 Apr 2015